| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$172,688 ) |
| | 2025 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AA028549 | Drug targeting the dynamics of opioid systems in alcohol dependence | 000 | 5 | NIH | 11/13/2024 | -$172,688 |
| | 2025 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AG065209 | Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk | 000 | 4 | NIH | 10/15/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $2,431,506 ) |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | Nobels Vag 6 | Solna | Solna | | | SWE | R01TS000348 | RFA-TS-24-010: Ambient Air Pollution as a Potential Risk Factor for ALS - Using a Multiomics Approach in a High-Quality Epidemiologic Study | 00 | 1 | CDC | 7/28/2024 | $299,567 |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01NS064964 | Restoration of Postural Control After Spinal Cord Injury | 000 | 9 | NIH | 7/26/2024 | $261,900 |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AA028549 | Drug targeting the dynamics of opioid systems in alcohol dependence | 000 | 5 | NIH | 7/4/2024 | $691,876 |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AG067996 | Repurposing drugs for Alzheimer´s disease using a reverse translational approach | 000 | 2 | NIH | 8/8/2024 | $488,631 |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R21DC021730 | Characterization of the cochlear aqueduct | 000 | 1 | NIH | 5/15/2024 | $149,716 |
| | 2024 | 2024 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01MH136156 | 3/3 Eating Disorders Genetics Initiative 2 (EDGI2) | 000 | 1 | NIH | 5/6/2024 | $539,816 |
| | 2024 | 2023 | Karolinska Institutet | Nobels Vag 6 | Solna | Solna | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 01 | 3 | CDC | 7/26/2024 | $0 |
| | 2024 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AG065209 | Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk | 000 | 4 | NIH | 10/11/2023 | $0 |
| | 2024 | 2022 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F31CA224806 | Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy | 000 | 4 | NIH | 12/28/2023 | $0 |
| | 2024 | 2022 | Karolinska Institutet | Nobels Vag 6 | Solna | Solna | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 01 | 3 | CDC | 7/26/2024 | $0 |
| | 2024 | 2021 | Karolinska Institutet | Nobels Vag 6 | Solna | Solna | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 01 | 3 | CDC | 7/26/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,940,713 ) |
| | 2023 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01NS064964 | Restoration of Postural Control After Spinal Cord Injury | 000 | 8 | NIH | 8/18/2023 | $272,523 |
| | 2023 | 2023 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R01AG065209 | Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk | 000 | 4 | NIH | 8/11/2023 | $359,398 |
| | 2023 | 2023 | Karolinska Institutet | Nobels Vag 6 | Solna | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 3 | CDC | 8/16/2023 | $493,735 |
| | 2023 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 001 | 3 | NIH | 8/25/2023 | $12,200 |
| | 2023 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 007 | 3 | NIH | 9/11/2023 | $12,200 |
| | 2023 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 004 | 3 | NIH | 9/7/2023 | -$12,200 |
| | 2023 | 2023 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R01MH122544 | A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study | 000 | 4 | NIH | 3/14/2023 | $283,669 |
| | 2023 | 2023 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | R01AA028549 | Drug targeting the dynamics of opioid systems in alcohol dependence | 000 | 4 | NIH | 8/29/2023 | $519,188 |
| | 2023 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 01 | 2 | CDC | 2/10/2023 | $0 |
| | 2023 | 2022 | Karolinska Institutet | Nobels Vag 6 | Solna | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 3 | CDC | 8/16/2023 | $0 |
| | 2023 | 2022 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 002 | 2 | NIH | 9/7/2023 | -$11,950 |
| | 2023 | 2022 | KAROLINSKA INSTITUTET | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 005 | 2 | NIH | 9/11/2023 | $11,950 |
| | 2023 | 2021 | Karolinska Institutet | Nobels Vag 6 | Solna | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 3 | CDC | 8/16/2023 | $0 |
| | 2023 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 01 | 2 | CDC | 2/10/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,058,127 ) |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 2 | CDC | 7/1/2022 | $498,395 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R01NS064964 | Restoration of Postural Control After Spinal Cord Injury | 000 | 7 | NIH | 8/16/2022 | $278,722 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | F31CA224806 | Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy | 003 | 4 | NIH | 9/26/2022 | $4,400 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01MH122544 | A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study | 000 | 3 | NIH | 2/22/2022 | $265,854 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01MH122544 | A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study | 001 | 3 | NIH | 6/6/2022 | $29,542 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R01AG065209 | Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk | 000 | 3 | NIH | 6/22/2022 | $450,076 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R01AA028549 | Drug targeting the dynamics of opioid systems in alcohol dependence | 000 | 3 | NIH | 7/8/2022 | $519,188 |
| | 2022 | 2022 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | F32DE029662 | Signaling mechanisms underlying neural crest cell fate decisions | 001 | 2 | NIH | 8/8/2022 | $11,950 |
| | 2022 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | F31CA224806 | Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy | 001 | 4 | NIH | 9/22/2022 | $0 |
| | 2022 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 2 | CDC | 7/1/2022 | $0 |
| | 2022 | 2019 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | | | | SWE | R21MH116188 | Schizophrenia Comorbidities: Common Genes and Clusters | 000 | 2 | NIH | 1/21/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $3,635,194 ) (Continued on the next page) |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01MH122544 | A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study | 000 | 2 | NIH | 3/9/2021 | $295,396 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01AA028549 | Drug targeting the dynamics of opioid systems in alcohol dependence | 000 | 2 | NIH | 7/1/2021 | $519,188 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | RF1AG067996 | Repurposing drugs for Alzheimer?s disease using a reverse translational approach | 000 | 1 | NIH | 8/11/2021 | $1,562,430 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | province | | | SWE | R01TS000324 | RFA-TS-21-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden | 00 | 1 | CDC | 9/8/2021 | $499,560 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01NS064964 | Restoration of Postural Control After Spinal Cord Injury | 000 | 6 | NIH | 7/22/2021 | $285,120 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | F31CA224806 | Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy | 002 | 4 | NIH | 3/16/2021 | $4,200 |
| | 2021 | 2021 | KAROLINSKA INST | NOBELS VAG 6 | SOLNA | STOCKHOLM | | | SWE | R01AG065209 | Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk | 000 | 2 | NIH | 7/16/2021 | $469,300 |
|
